10 Small Cap Stocks with Potential to Rise 1000 Percent
In this article, we look at 10 Small Cap Stocks with Potential to Rise 1000 Percent. Small-cap stocks have returned to the market’s risk conversation in 2026.
Olema Pharmaceuticals Inc. (OLMA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 332,418 | $2,872,090 | +13% | 0% |
| 2. | 15,000 | $129,600 | 0% | ||
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 11,000 | $95,040 | 0% | |
| 4. | Hurley Capital Charles Goldblum | 29 | $251 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.76 | 300,000 | $1,727,370.00 | 7,800,000 | 2025-01-08 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 700,761 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 1,408,875 | 2024-12-17 | Filing | |
| $13.09 | 50,000 | $654,250.00 | 1,800,000 | 2023-12-05 | Filing | |
| $14.95 | 50,000 | $747,480.00 | 1,750,000 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.71 | 12,500 | $146,425.00 | 702,770 | 2026-07-24 | Filing | |
| $11.58 | 12,500 | $144,737.50 | 715,270 | 2026-07-23 | Filing | |
| $24.69 | 233 | $5,752.77 | 0 | 2026-03-04 | Filing | |
| $24.25 | 24,767 | $600,599.75 | 233 | 2026-03-04 | Filing | |
| $23.01 | 15,000 | $345,150.00 | 0 | 2026-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,969,909 | $17,023,358 | 0% | |
| 2. | 1,552,837 | $13,415,730 | 0% | |
| 3. | 1,184,467 | $10,271,186 | 0.05% | |
| 4. | 421,061 | $3,637,967 | 0.11% | |
| 5. | 339,461 | $2,932,938 | 0.01% |
News See All
Citi, Stifel Bullish on Olema (OLMA) Despite COO Departure
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is one of 15 stocks with the biggest hedge fund momentum, after gaining 28 hedge fund holders during the fourth quarter of 2025.
15 Stocks with the Biggest Hedge Fund Momentum
In this article, we talk about the 15 stocks with the biggest hedge fund momentum.
Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating
Olema Pharmaceuticals (NASDAQ:OLMA) is one of the 17 biotechnology stocks with more than 50% upside.
17 Biotechnology Stocks with More Than 50% Upside
2025 was a year characterized by both challenges and opportunities for the biotechnology sector.
10 Best Small-Cap Stocks Ready to Explode in 2026
In this article, we will look at the 10 Best Small-Cap Stocks Ready to Explode in 2026.
Wall Street Remains Bullish on Olema Pharmaceuticals Inc. (OLMA)
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is among the 14 best booming stocks to buy right now. On January 7, UBS initiated coverage of the stock with a Buy rating and set a $45 price target.
14 Best Booming Stocks to Buy Right Now
This article looks at the 14 Best Booming Stocks to Buy Right Now.
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT
We recently published 10 Stocks Boasting the Biggest Gains; 4 Hit Record Highs. Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is one of the best performers on Wednesday.
Guggenheim Initiates Olema Pharmaceuticals (OLMA) Coverage with Buy Rating and $20 PT, Cites Palazestrant Potential
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is one of the best hot stocks to invest in. On October 8, Guggenheim initiated coverage of Olema Oncology with a Buy rating and $20 price target.
Hedge Fund Resource Center